Sun Pharmaceutical Industries Ltd.
33
MENTIONS
25
EPISODES
21
PODCASTS
Search complete. 33 mentions across 25 episodes found for "Sun Pharmaceutical Industries Ltd.".
Sep 10, 2026
Shakthi HarikrishnanHOST
The funds will support airport expansion, airport city developments and non-aeronautical businesses, with the investment to be completed in three tranches by July 2027.
Shakthi HarikrishnanHOST
The rapid growth of GLP-1 weight loss drugs is prompting pharmaceutical companies to expand into wellness and nutraceuticals, with companies such as Sun Pharma, USV, and Cipla acquiring businesses in the sector.
Shakthi HarikrishnanHOST
The shift reflects growing interest in nutritional products that can complement GLP-1 treatments.
Shakthi HarikrishnanHOST
The US Department of Labor has suspended Cognizant's PREM applications, alleging fraudulent practices involving the employment-based immigration program.
Maya PatelHOST
The White House added nine more manufacturers to its most favored nation pricing agreements on Monday.
Maya PatelHOST
Alcon, Astellas, B1, Bridge Bio, CSL, Keogh-Wukiran, Sun Pharma, Teva, and UCB.
Maya PatelHOST
That takes the program to 26 companies and, by the administration's count, 89% of the branded market.
Maya PatelHOST
What the nine committed to is Medicaid access at MFN prices and MFN pricing on new launches, plus a collective pledge of at least $19.6 billion in U.S. manufacturing.
Donald TrumpSOUNDBITE_SPEAKER
They're largely standing behind me.
Donald TrumpSOUNDBITE_SPEAKER
I want to thank The president of Astellas Pharma Medical, Michael Putratis, and CEO of B1 Medicines, John Euler, CEO of Bridge Bio, Neil Kumar, Senior Vice President of CSL, Julie Schiffman, CEO of Sun Pharma, Rick Ashcroft, President of Keio Kirin, Steve Schaefer, Executive Vice President of Teva Pharmaceuticals USA, Christine Fox, CEO of UCB, Dr. Jean-Christophe Tellier.
Donald TrumpSOUNDBITE_SPEAKER
I think I got those names almost right.
Donald TrumpSOUNDBITE_SPEAKER
That's a group of very interesting names.
29 MINS LATER
Rick AshcroftSOUNDBITE_SPEAKER
Thank you, Mr.
Rick AshcroftSOUNDBITE_SPEAKER
President, and thank you to the teams at Health and Commerce for their collaboration in this effort.
Rick AshcroftSOUNDBITE_SPEAKER
I'm pleased to represent Sun Pharma and the patients we serve.
Rick AshcroftSOUNDBITE_SPEAKER
For over 40 years, our mission has been to reach patients and touch lives, and these agreements allow us to further that mission.
Dan BallHOST
It makes good business sense.
Dan BallHOST
Alcon, Astrellas Pharma, Sun Pharma, six others, now provided discounting prices on drugs that treat a huge range of conditions.
Dan BallHOST
And by the way, every state Medicaid program in the entire country is gonna have access to these huge discounts.
Dan BallHOST
The Trump administration yet to say which medicines, I'm sure it's going to be a huge number of them, will be impacted.
MockHOST
And for a little bit more detail, we've got another screenshot here that lists the manufacturers.
MockHOST
It includes Alcon, Bridge Bio, Sun Pharma, a whole bunch of them.
MockHOST
And these reduced prices on drugs that treat a whole bunch of different expensive, chronic, rare diseases, including hemophilia, Parkinson's, glaucoma, liver disease, various forms of cancer.
MockHOST
So this was a big announcement.
Donald TrumpSOUNDBITE_SPEAKER
Senior Vice President of CSL, Julie Schiffman.
Donald TrumpSOUNDBITE_SPEAKER
CEO of Sun Pharma, Rick Ashcroft.
Donald TrumpSOUNDBITE_SPEAKER
President of Keogh Kiran, Steve Schaffer.
Donald TrumpSOUNDBITE_SPEAKER
Executive Vice President of Teva Pharmaceuticals USA, Christine Fox, CEO of UCB, Dr. Jean-Christophe Tellier.
28 MINS LATER
Rick AshcroftSOUNDBITE_SPEAKER
Thank you, Mr.
Rick AshcroftSOUNDBITE_SPEAKER
President, and thank you to the teams at Health and Commerce for their collaboration in this effort.
Rick AshcroftSOUNDBITE_SPEAKER
I'm pleased to represent Sun Pharma and the patients we serve.
Rick AshcroftSOUNDBITE_SPEAKER
For over 40 years, our mission has been to reach patients and touch lives, and these agreements allow us to further that mission.
Dan NewmanHOST
President Trump had a bunch of pharmaceutical experts in his office yesterday, and he has reached a deal with nine more of those pharmaceutical companies to slash the drug prices.
Dan NewmanHOST
He announced the deals with Alcon, Estella's Pharma, B1 Medicines, Bridge Bio, CSL, Kiowa, Kirin, Sun Pharma, Teva Pharmaceuticals, and UCB.
Dan NewmanHOST
And it happened in the Oval Office, and he was flagged by those pharmaceutical executives.
Dan NewmanHOST
Now, why would you even talk about this, Dan? Folks, do you understand that what he has already done in the first batch, in the second batch of these happenings, The prices that we Americans are paying on drugs that have been forever oodles more than the same drugs are being sold all across the world.
MockHOST
And for a little bit more detail, we've got another screenshot here that lists the manufacturers.
MockHOST
It includes Alcon, Bridge Bio, Sun Pharma, a whole bunch of them.
MockHOST
And these reduced prices on drugs that treat a whole bunch of different expensive, chronic, rare diseases, including hemophilia, Parkinson's, glaucoma, liver disease, various forms of cancer.
MockHOST
So this was a big announcement.
Joe PiscopoHOST
So the agreements bring the total number of pharmaceutical companies deals to 26, which covers 89 percent of the branded drug market.
Joe PiscopoHOST
And the nine manufacturers, I don't know, I don't really Sun Pharma.
Joe PiscopoHOST
I don't recognize them.
Joe PiscopoHOST
And then I'm ready to go meet with R.K. Jr. because I have friends who want to make the pharmaceuticals where I don't know where they're making these pharmaceuticals.
15 more episodes mention Sun Pharmaceutical Industries Ltd..
Create an account to see the whole feed, search across every transcript, and follow the entities you care about.